Call picture

Research call on drug resistance now open

The transnational project call Disrupting drug resistance using innovative design is now open. The call involves 27 funding organisations from 18 countries and the total estimated call budget is about 19 million Euro.

This call aims to improve the treatment of bacterial and fungal infections (including co-infection) and/or the prevention of the emergence/spread of resistance in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents.

The call will follow a two-step evaluation procedure and the deadline for pre-proposals is 8 March 2022.

Read more on the Disrupting drug resistance using innovative design call page.

Transmission dynamics 2016 call picture

Main achievements of the AMR Transmission Dynamics call

The outputs, outcomes and the impact generated by the projects supported under the 2016 JPIAMR joint co-funded call “AMR Transmission Dynamics have now been published in a report. The report highlights the effect of supporting excellent science through transnational research collaborations.

Numerous peer-reviewed scientific articles in highly recognised journals have been published by the supported projects on the research findings, and a patent has been filed on a new peptide molecule discovered in one of the projects.

Other impact highlights are:

  • New knowledge generation to address AMR at regional, national and global scale with a One Health approach.
  • Science-based policy and societal impact.
  • Innovative tools and analytical methods and technologies.
  • Interdisciplinary expertise in transnational collaboration.

Download the report (pdf 1 MB): 2016 call on AMR Transmission Dynamics: Research outputs, outcome and impact of the projects

AMR Transmission Dynamics call

The third JPIAMR joint co-funded call “AMR Transmission Dynamics” was launched in 2016. The call was conducted by 21 participating funding organisations from 18 countries and was co-funded by the European Commission (EC) within the JPI-EC-AMR ERA-Net co-fund grant . The call resulted in the awarding of 29.1 million euros (M EUR) including a 6.3 M EUR contribution from the EC to 19 research projects. The 19 project consortia included a total of 118 researchers from 16 countries aiming to bridge the knowledge gap on AMR transmission mechanisms.

The call was one of the first of its kind to address transmission of antibiotic resistance following a One Health approach not only focussing the European and North American countries but also including research activities in the low- and middle-income countries (LMIC).

Flag of Chile

Chile new member of JPIAMR

We are pleased to welcome Chile as a new member of JPIAMR. Chile’s participation in JPIAMR is part of the country’s determination to become an active contributor to the world’s efforts to tackle the global challenge of AMR.

Chile is represented in JPIAMR by MICROB-R on behalf of the Ministry of Health.

Tania Herrera, Coordinator Chile National AMR Plan:

-As an JPIAMR member, we expect to advance collaborative efforts on ambitious, innovative, large scale research projects, introducing meaningful progress in our knowledge base to tackle the global challenge of AMR.

Andrea Moreno Switt, Associate Professor, Pontificia Universidad Católica de Chile:

-In the context of Chile’s newly launched version of its AMR National Plan, JPIAMR membership represents our renewed efforts and conviction that Chilean agenda and capabilities on AMR research are having a substantial upgrade, and that we are in solid shape to undertake collaborative projects benefiting the international AMR research community.

Jan-Ingvar Jönsson, JPIAMR Chair:

On behalf of the JPIAMR Management Board, I am extending a warm welcome to Chile as the 29th member of JPIAMR. It is with great pleasure and excitement that we are including yet another country in Latin America. We are looking forward to create opportunities for researchers in Chile to participate in future calls. The membership will unlock new research collaborations that may contribute to a deeper understanding of AMR and potentially, solutions to one of the key challenges of our time.

Read more on Chile’s national AMR research program and activities.

JPIAMR celebrating 10 years

JPIAMR celebrating 10 years of achievements

It is with great pleasure that we acknowledge that JPIAMR officially celebrates ten years as an international collaborative platform. From its inception in December 2011 until today, JPIAMR has achieved and exceeded its mission to coordinate national funding of antimicrobial resistance (AMR) research, guided by a shared strategic research and innovation agenda. Today 28 countries fund AMR research with a One Health approach, as members of JPIAMR. More than 1 400 researchers in 71 countries have been engaged in research that has been funded by JPIAMR members. In total, 125 million Euros have been allocated to research and networking which has achieved outstanding results and impacts. This highlights the role of JPIAMR as a key initiative helping to understand and curb AMR on a global scale.

JPIAMR is leading the development of the One Health AMR Partnership within the Horizon Europe Framework Programme. We look forward to working together with members to seek and support solutions to curb AMR.

Jan-Ingvar Jönsson, JPIAMR Chair:

It is impressive to see what JPIAMR members have made possible during these ten years. The results from funded research are astonishing and important, showing that the JPIAMR model works. JPIAMR is well suited to lead the development of the One Health AMR Partnership. We can only imagine what will be achieved in the ten years to come. I am joining all of the members and the AMR research community in wishing JPIAMR a Happy Birthday!

Call picture

Pre-announcement: Research call on drug resistance

We are pleased to pre-announce the transnational project call Disrupting drug resistance using innovative design under the umbrella of the JPIAMR. The call will involve 26 funding organisations from 17 countries and the total estimated call budget is about 17 million Euro.

This call aims to improve the treatment of bacterial and fungal infections (including co-infection) and/or the prevention of the emergence/spread of resistance in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents.

The call opens on 11 January 2022.

Read more on the Disrupting drug resistance using innovative design call page.

Diagnostics and Surveillance Networks call image

Pre-announcement: Diagnostics and surveillance network call

JPIAMR is launching the call Diagnostics and Surveillance Networks in April 2022 with the aim to assemble networks of leading experts and stakeholders with an intent to facilitate the development, optimisation and use of diagnostic and surveillance tools, technologies and systems.

Eleven (11) JPIAMR-ACTION members are participating in this network call to date. Each network coordinator will be able to apply for a maximum of 50,000 Euro for 12 or 24 months period for support of its activities.

Read more on the Diagnostics and Surveillance Networks call page.

JPIAMR awards new projects in the area of transmission and interventions

Nineteen projects involving 114 partners from 35 different countries have been recommended for funding within the JPIAMR 13th transnational call One Health interventions to prevent or reduce the development and transmission of antimicrobial resistance. The total funding amount is 25,6 M€.

The call, launched in January 2021, was within the framework of the ERA-NET JPIAMR-ACTION and supported by 30 research funding organisations from 21 countries and by the European Commission. Using a One Health approach, the call aimed to understand the impact of interventions on the development and transmission of antibiotic resistance and to design, implement, evaluate, and compare interventions reducing the development and transmission of antibiotic resistance. Applicants were encouraged to consider the use of interventions that may have an impact in areas where the risk and burden of AMR is greatest, such as in Low and Middle Income countries.

The projects recommended for funding are:

New SAB members appointed

JPIAMR is pleased to welcome the nine new Scientific Advisory Board (SAB) members that have been appointed by the JPIAMR Management Board for the period 2022-2024. The new members are:

  • Ana Alastruey, Instituto de Salud Carlos III, Spain
  • Uga Dumpis, Pauls Stradiņš University Hospital, Latvia
  • Sabiha Essack, University of KwaZulu Natal, South Africa
  • Luca Guardabassi, University of Copenhagen, Denmark
  • Christian Giske, Karolinska Institute, Sweden
  • Geetanjali Kapoor, Center for Disease Dynamics, Economics & Policy, India
  • Joakim Larsson, University of Gothenburg, Sweden
  • Nilton Lincopan, Universidade de São Paulo, Brazil
  • Kornelia Smalla, Julius Kühn Institute, Germany

Read more about the JPIAMR Scientific Advisory Board

Team in rowing boat

Work with us!

The JPIAMR Secretariat is looking for a senior research officer with a background in medicine and health. With us, you get to work with committed colleagues in an international context to strengthen research and research collaboration on antimicrobial resistance. You will be employed by the Swedish Research Council (Vetenskapsrådet), based in central Stockholm, and also take part in the work on the Swedish national research programme on antibiotic resistance.

Senior research officer focusing on antimicrobial resistance

Stockholm

Ref 2.2.1-2021-06611

Antimicrobial resistance is a global problem that impacts on us all. Resistance in bacteria leads to infections that are difficult to treat, and means that complicated medical interventions can not longer be carried out without functioning antibiotics. It is difficult to develop new antibiotics, and we are also at risk of bacteria quickly developing resistance to them through careless and incorrect use. To increase the impact of research, Sweden established a national research programme on antibiotic resistance in 2016, and has since 2011 been one of the driving countries within the global research collaboration Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). Today, JPIAMR involved around thirty countries across the world, and is also receiving strong support from the European Commission. The Swedish Research Council is coordinating the collaboration, and is responsible for the joint JPIAMR Secretariat.

Role and job description

We are offering a role as senior research officer within the field of medicine and health, where you together with knowledgeable and committed colleagues are part of the secretariat that the Swedish Research Council provides for the international collaboration Joint Programming Initiative Antimicrobial resistance (JPIAMR, www.jpiamr.eu). You will also take part in the work on the national research programme on antibiotic resistance, and may also be included in other tasks within the department. The role requires some travel (under normal circumstances), primarily within the EU.

The tasks include:

  • supporting the global collaboration, together with the other personnel at the JPIAMR Secretariat, which includes
    • taking part in the design and implementation of JPIAMR’s strategic research agendas
    • designing, implementing and administrating joint international calls
    • designing and implementing conferences and workshops, following up and analysing research funded by JPIAMR
    • leading work teams and collaborations between the member countries
    • initiating and implementing communication inputs and maintaining contacts with international partners and stakeholders
    • providing scientific and technical advice linked to antimicrobial resistance
    • supporting the direction of the collaboration through coordination and communication between the various JPIAMR steering groups, including producing relevant documents, overviews and reports
  • consulting with other national programmes to drive the national research programme for antibiotic resistance, which includes
    • consulting with experts in the area to update and implement strategic research agendas.
    • consulting with experts in the area to implement national and international calls, conferences and workshops
    • implementing communication initiatives and maintaining and developing national networks of relevance for antibiotic resistance
    • following up the research funded via the national programme
    • coordinating the national research programme with the European framework programme and the global collaboration JPIAMR
  • monitoring international research in antimicrobial resistance, including resources invested and research priorities
  • plus other tasks arising within the Swedish Research Council, such as taking part in department analysis and evaluation.

Your background

You must have:

  • experience of coordinating and providing strategic support to international research collaborations
  • good overall knowledge of, and working networks within, the medical research field in Sweden
  • a doctoral degree or corresponding within an area of relevance to antimicrobial resistance (microbiology, infectious diseases, or similar)
  • good knowledge of Swedish and English, both spoken and written, as the working language within the JPIAMR Secretariat is primarily English
  • experience of project management
  • good ability to absorb and communicate scientific information, both spoken and written, in a way suited to the target group
  • worked with research and its importance for societal development

It is an advantage if you have:

  • experience of own research activities in a field of relevance to antimicrobial resistance
  • experience from Swedish public administration, HEI management, public agency in a relevant factual area, or similar, good knowledge of EU institutions and working methods
  • experience of managing and administering EU projects
  • experience of working with international collaboration partners
  • experience of implementing international calls with peer review

Your personal qualities

We are looking for a person who is committed, proactive, and has well-developed strategic thinking. You must like taking initiatives and working independently, and at the same time communicate well and establish good and trusting relationships, in internal as well as national and international collaboration. We value good organisational skills and a prestige-free attitude very highly, as well as flexibility and the ability to multitask.

We put great emphasis on your personal qualities.

Location

Our offices are at Västra Järnvägsgatan 3 in central Stockholm. In April 2022 we will be moving to Hantverkargatan 11 in Stockholm.

Employment form and start date

We are offering permanent full-time employment, with a 6-month trial employment. We would like you to start as soon as possible, taking into account any notice period.

Are you interested?

If you want to learn more about this position, please contact:

  • Elisabeth Sjöstedt, Unit Manager, +46 8 546 44 014
  • Anders Weström, Unit Manager, +46 8 546 44 318
  • Johan Karmhed, HR Administrator, +46 8 546 44 064
  • Erika Godoy, representing SACO-S, +46 8 546 44 029
  • Anneli Fröjd, representing ST, +46 8 546 44 333

How to apply

Please send us your CV and a personal letter via our recruitment system (form in Swedish) no later than 26 September 2021.
Please mark your application with registration number 2.2.1-2021-06611.

The Swedish Research Council is Sweden’s largest governmental research funding body. The work of the Swedish Research Council is about giving researchers good opportunities to contribute to society with research of the highest quality. Around 250 persons work for us, at offices located centrally in Stockholm and Gothenburg. We manage research applications, evaluate and follow up the conditions for research, and communicate about research. Read more about our workplace and meet some of our staff members at Vetenskapsrådet.se.